DUBLIN--(BUSINESS WIRE)--The "Over The Counter/OTC Test Market by Product and Technology - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period.
Diabetes is a prominent affliction across the globe and a key contributor to the demand for OTC tests. Infectious diseases also require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.
"The infectious disease tests segment is expected to grow at the highest CAGR during the forecast period."
The OTC Test market, by product, has been categorized into eight major segments - glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and other tests. The infectious disease tests segment is estimated to grow at the highest CAGR during the forecast period.
This market is majorly driven by factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China
"Asia Pacific projected to grow at the highest CAGR during the forecast period."
In the OTC Test market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for OTC Test in the Asia Pacific. An increasing prevalence of target conditions and infectious diseases and growing patient population base in emerging countries like India and China are expected to drive the growth of these markets during the forecast period.
The OTC Test market comprises major providers such as OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). The study includes an in-depth competitive analysis of these key players in the OTC Test market, along with their company profiles, recent developments, and key market strategies.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Diabetes
5.2.1.2 High Prevalence of Infectious Diseases in Developing Countries
5.2.1.3 Growing Support and Collaboration for Developing OTC Tests
5.2.2 Opportunities
5.2.2.1 Introduction of Combined Kits for Testing Pregnancy and Ovulation
5.2.3 Challenges
5.2.3.1 Invasiveness of Blood Glucose Monitors and Cholesterol Monitors
6 Over the Counter Tests Market, By Technology
6.1 Introduction
6.2 Lateral Flow Assays
6.2.1 Lateral Flow Assays to Register the Highest Growth During the Forecast Period
6.3 Immunoassays
6.3.1 Increasing Use of Immunoassays for Pregnancy & Infectious Disease Testing is Driving Market Growth
6.4 Dipsticks
6.4.1 Dipsticks Provide Only A Qualitative Analysis, Which is A Major Factor Restraining Market Growth
7 Over the Counter Tests Market, By Product
7.1 Introduction
7.2 Glucose Monitoring Tests
7.2.1 Glucose Monitoring Tests Dominated the OTC Tests Market in 2018
7.3 Pregnancy & Fertility Tests
7.3.1 Advantages of Pregnancy & Fertility Tests Have Driven Companies to Focus on Product Development
7.4 Infectious Disease Tests
7.4.1 Increasing Prevalence of Infectious Diseases is Driving Market Growth
7.5 Coagulation Monitoring Tests
7.5.1 Coagulation Monitoring Tests Provide Quick and Reliable Results
7.6 Urinalysis Tests
7.6.1 Increasing Prevalence of Urinary Tract Infections is A Major Factor Driving Market Growth
7.7 Cholesterol Tests
7.7.1 Convenience of Home-Use Tests has Expanded their Use
7.8 Drugs-Of-Abuse Tests
7.8.1 Rising Production and Consumption of Illegal Drugs Have Driven the Focus on Testing
7.9 Other Tests
8 Over the Counter Tests Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 US to Dominate The North America OTC Tests Market
8.2.2 Canada
8.2.2.1 Increasing Government Initiatives to Support the Adoption of POC Products to Drive Market Growth in Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany is the Fastest-Growing Market in Europe
8.3.2 France
8.3.2.1 High Demand for Glucose Testing Kits to Drive Market Growth in France
8.3.3 UK
8.3.3.1 Increasing Awareness of Oct Tests Among the Users
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Asia Pacific is the Fastest-Growing Segment of the Global OTC Tests Market
8.5 Rest of the World
9 Competitive Landscape
9.1 Overview
9.2 Vendor Benchmarking
9.3 Competitive Leadership Mapping
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Dynamic Differentiators
9.3.4 Emerging Companies
9.4 Market Ranking Analysis, 2017
9.5 Competitive Situation and Trends
9.5.1 Product Launches
9.5.2 Collaborations, Partnerships, and Agreements
9.5.3 Acquisitions
10 Company Profiles
10.1 Roche Diagnostics
10.2 Abbott Laboratories
10.3 Orasure Technologies
10.4 Accubiotech
10.5 LIA Diagnostics
10.6 Labstyle Innovations
10.7 SD Biosensor
10.8 Acon Laboratories Inc
10.9 Sinocare
10.10 Nowdiagnostics Company
10.11 iHealth Lab
10.12 Biolytical Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/ew2tqw
